Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 3/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | RGS12 | O14924 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19381442 | 0.83 | KCNN4 (0.46) | KCNN4SLC6A4CYP2D6CYP1A2CYP2C19 | |
| SCHEMBL27365381 | 0.81 | KCNN4 (0.54) | KCNN4SLC6A4CYP2D6CYP1A2CYP2C19 | |
| SCHEMBL9025613 | 0.77 | KCNN4 (0.50) | KCNN4SLC6A4CYP2D6CYP1A2CYP2C19 | |
| SCHEMBL16673174 | 0.77 | KCNN4 (0.50) | KCNN4SLC6A4CYP2D6CYP1A2CYP2C19 | |
| SCHEMBL2160833 | 0.77 | KCNN4 (0.50) | KCNN4SLC6A4CYP2D6CYP1A2ADRA2C | |
| SCHEMBL10675289 | 0.77 | KCNN4 (0.50) | KCNN4SLC6A4CYP2D6CYP1A2CYP2C19 | |
| SCHEMBL9037241 | 0.77 | KCNN4 (0.45) | KCNN4CYP2D6CYP1A2CYP2C19KIF11 | |
| SCHEMBL11128706 | 0.77 | KCNN4 (0.45) | KCNN4CYP2D6CYP1A2CYP2C19KIF11 | |
| SCHEMBL2552806 | 0.77 | KCNN4 (0.45) | KCNN4SLC6A4CYP2D6CYP1A2CYP2C19 | |
| SCHEMBL16550481 | 0.77 | KCNN4 (0.50) | KCNN4SLC6A4CYP2D6CYP2C19HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-63054384-A | — | — | None | — | — | JP | disclosed |
| US-20250215028-A1 | SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS | UNIVERSITE DE ROUEN-NORMANDIE (FR) | 2025-07-03 | — | — | US | disclosed |
| US-9115122-B2 | Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK) | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2015-08-25 | — | — | US | disclosed |
| EP-2845587-A2 | Melanin production inhibitor | Pola Chemical Industries Inc. (JP) | 2015-03-11 | — | — | EP | disclosed |
| US-20140179743-A1 | NON-ATP DEPENDENT INHIBITORS OF EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2014-06-26 | — | — | US | disclosed |
| US-7517858-B1 | Prodrugs of pharmaceuticals with improved bioavailability | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-04-14 | — | — | US | disclosed |
| EP-0837630-B1 | PRODRUGS OF PHARMACEUTICALS WITH IMPROVED BIOAVAILABILITY | HOSTETLER KARL Y (US) | 2007-12-26 | — | — | EP | disclosed |
| EP-1196383-B1 | PROCESS FOR PREPARING AMLODIPINE BENZENESULPHONATE | RICHTER GEDEON VEGYESZET (HU) | 2004-12-01 | — | — | EP | disclosed |
| WO-2003101965-A1 | TWO CRYSTALLINE HYDRATE FORMS OF AMLODIPINE BENZENESULFONATE OF HIGH PURITY, PROCESSES FOR THEIR PREPARATION AND USE | LEK PHARMACEUTICALS D.D. (SI) | 2003-12-11 | — | — | WO | disclosed |
| US-6596874-B1 | Salt formation by reaction using benzenesulfonic acid | RICHTER GEDEON VEGYESZETI GYAR RT. (HU) | 2003-07-22 | — | — | US | disclosed |
| US-5245038-A | Fluorescent poly(arylpyridine) rare earth chelates | BAXTER DIAGNOSTICS INC. (US) | 1993-09-14 | — | — | US | disclosed |
| EP-0556216-A1 | PHOSPHORIC ACID ESTERS AND THEIR USE IN THE PREPARATION OF BIOCOMPATIBLE SURFACES. | BIOCOMPATIBLES LTD (GB) | 1993-08-25 | — | — | EP | disclosed |
| US-5116989-A | Fluorescent poly(arylpyridine) rare earth chelates | BAXTER DIAGNOSTICS INC. (US) | 1992-05-26 | — | — | US | disclosed |
| WO-1992007858-A1 | PHOSPHORIC ACID ESTERS AND THEIR USE IN THE PREPARATION OF BIOCOMPATIBLE SURFACES | BIOCOMPATIBLES LIMITED (GB) | 1992-05-14 | — | — | WO | disclosed |
| US-5106957-A | Fluorescent poly(arylpyridine) rare earth chelates | BAXTER DIAGNOSTICS INC. (US) | 1992-04-21 | — | — | US | disclosed |
| US-5055578-A | Fluorescent poly(arylpyridine) rare earth chelates | BAXTER DIAGNOSTICS INC. (US) | 1991-10-08 | — | — | US | disclosed |
| US-5032677-A | Fluorescent poly(arylpyridine) rare earth chelates | BAXTER INTERNATIONAL INC. (US) | 1991-07-16 | — | — | US | disclosed |
| EP-0383281-A1 | 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same | TOYAMA CHEMICAL CO., LTD. (JP) | 1990-08-22 | — | — | EP | disclosed |
| EP-0341298-A1 | FLUORESCENT POLY(ARYLPYRIDINE) RARE EARTH CHELATES | Baxter Diagnostics Inc. (US) | 1989-11-15 | — | — | EP | disclosed |
| JP-S6354384-A | MIXED ACID-TYPE POLYMERIZABLE PHOSPHOLIPID DERIVATIVE AND PRODUCTION THEREOF | TOSOH CORP | 1988-03-08 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250215028-A1 | SYNTHETIC GLYCEROPHOSPHOLIPIDS COMPRISING AT LEAST ONE REACTIVE FUNCTION, PROCESS FOR PREPARING SAME AND USES THEREOF IN DIFFERENT APPLICATIONS | PHOSPHO1, SGMS1, SGPL1 | KCNN4 3964/4885SLC6A4 4576/4885CYP2D6 1978/4885 |
| US-20140179743-A1 | NON-ATP DEPENDENT INHIBITORS OF EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) | MAPK1, MAP3K1, MAP3K20 | KCNN4 4035/4885SLC6A4 4396/4885CYP2D6 2884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.